14

Nov2023
First Step of The New Guidelines Consultation Announced On October 25, 2023, the Patented Medicine Prices Review Board (PMPRB) released details on the first  of its two-step consultation process for developing its new set of price regulatory guidelines. PMPRB will send invitations to stakeholders for ... Read More

13

Nov2023
On November 10, 2023, the Patented Medicine Prices Review Board (PMPRB) launched first phase of its consultation process towards development of new price regulatory Guidelines. PMPRB published its Scoping Paper for the Consultations on the Board’s Guidelines and invited feedback to be provided either ... Read More

02

Oct2023
On September 27, 2023, the Patented Medicine Prices Review Board (PMPRB) published its final decision regarding the Amended Interim Guidance first proposed on June 20, 2023.Effective immediately, the proposed amendments to the Interim Guidance are implemented without changes, notwithstanding the concerns raised by many of the ... Read More

11

Jul2023
On June 6, 2023, the Patented Medicine Prices Review Board (PMPRB) released its first NEWSletter of 2023, providing updates on recent activities among the Board and Board staff. Updates from the NEWSletter and PDCI’s insights on potential implications are summarized below.  Despite recent quietness from PMPRB on its ... Read More

11

Jul2023
On June 20, 2023, PMPRB published proposed amendments to the Interim Guidance relating to  New Medicines. PMPRB has invited stakeholders to comment on the approach before August 21, 2023 (60-day consultation). After stakeholder consultation, a new set of guidelines is anticipated to be finalized in 2024.... Read More

07

Mar2023
In the wake of media attention around recent high-profile resignations from PMPRB, Melanie Bourassa Forcier, former Acting Chairperson of the PMPRB who resigned in December, came forward to "rectify the facts” about her reasons for resigning this past weekend.In her 5-page letter dated March 3rd and published on ... Read More

24

Feb2023
On February 24, 2023, Doug Clark announced he is stepping down from his position as Executive Director of the PMPRB after almost a decade with PMPRB. Clark will continue to serve as a special advisor to the Board as he transitions to retirement from the federal public service. ... Read More

24

Feb2023
On February 23, 2023, Matthew Herder, a PMPRB Board Member since 2018, publicly announced his resignation from the PMPRB. He shared his resignation letter on his personal twitter page today. The letter, which he notes was submitted to Health Minister Jean-Yves Duclos on Monday, outlines his reasons for parting ways with ... Read More

13

Feb2023

PMPRB New Chairperson

On Wednesday, February 1, 2023, the Minister of Health announced the appointment of Thomas J Digby as the new Chairperson for the PMPRB. This nomination comes after over a year of being vacant when Dr. Mitchell Levine completed his five-year term tenure on November 2021. Thomas J. Digby ... Read More

19

Dec2022
Mélanie Bourassa Forcier, Vice-Chairperson and Acting Chairperson of the Patented Medicine Prices Review Board (PMPRB), confirmed her resignation from the Board on Twitter on December 7, 2022. In her comment she indicated she is evaluating her legal obligations concerning whether she can share the reasons for her ... Read More